Launch of the first canine biobank in Westies to support human and canine health research efforts

Westies may hold the key to deadly human and canine diseases

Westie Foundation of America and Resero Genomics Announce Canine Genetics and DNA Bank Alliance

This is an important step in our efforts to help move science forward faster for our dogs and humans through our One Health approach.

—Bebe Pinter, President of the Westie Foundation of America

HOUSTON, Texas, USA, Nov. 14, 2022 /EINPresswire.com/ — The Westie Foundation of America (WFA), a 501(c)3 nonprofit organization dedicated to West Highland health and wellness White Terrier, and Resero Genomics, a global leader in genomics services, today announced an alliance that will provide the world’s first West Highland White Terrier biobank.

Storing Westie DNA samples will provide a tool to help better understand the diseases that afflict the West Highland White Terrier as well as other canine breeds. It will also provide DNA sources for the research efforts of veterinary researchers and human medicine researchers working to solve some of the most devastating diseases that occur in both dogs and humans.

“The WFA is honored to partner with Resero Genomics on this monumental milestone for the health of our Westie breed,” said Bebe Pinter, President of the Westie Foundation of America. “This is an important step in our efforts to help move science forward faster for our dogs and humans through our One Health approach.”

Known as One Health, the translational benefits of studying naturally occurring diseases are increasingly recognized in the veterinary and human sciences. Taking information from diseases in domestic animals and comparing it to human diseases has been shown to dramatically reduce the time it takes for a given therapy to move from bench to bedside in human patients and in dogs. Diseases such as cancer, fibrosis and atopic dermatitis, which are relatively common in pets, urgently require therapies. These natural models can often provide a more accurate disease model than many mouse models that are currently widely used and known to have limitations, often unable to translate to humans.

One Health continues to gain traction as a viable and important part of human research. Recently, US Senator Kristen Gillibrand introduced a groundbreaking One Health bill to prevent, detect and respond to biological threats. More information about the bill can be found here:
https://www.gillibrand.senate.gov/news/press/release/senator-gillibrand-introduces-groundbreaking-one-health-bill-to-prevent-detect-and-respond-to-biological-threats

Naturally occurring diseases in dogs, in particular, helped usher in therapies for humans, including in bladder and other forms of cancer. In fibrosis, especially in idiopathic pulmonary fibrosis, the most common interstitial lung disease and a fatal disease without life-saving treatment. Mouse models often show positive results in multiple drug trials only to later fail in human studies, costing years of research effort, billions of dollars in funding, and giving heartbreaking results to patients. , families and medical experts working to help them. Having genetic information about animals suffering from diseases such as IRS offers a way to help them and the humans who suffer from it.

“Since we launched our DNA banking services for dog owners, we’ve had tremendous success,” said Jared Larsen, head of genomics at Resero Genomics. “Those who have chosen to be part of our research program have enabled Resero to make significant advances in understanding genetic abnormalities within various dog breeds and we are excited to continue this progress.”

DNA storage
The goal of Resero Genomics, which has been successfully storing and maintaining animal and human DNA since 2003, is to provide secure, long-term storage of DNA. The Westie Foundation of America Biobank will provide an option for Westie owners to include their animals’ DNA, Westie owners can learn more about requesting a kit to include their dogs’ DNA in the biobank by visiting: http: //westiefoundation.org/BioBank

The WFA worked with Westie owners to collect DNA samples for medical and veterinary research: erinarians. An article by Tufts explains the significance of their One Health study: https://now.tufts.edu/2020/02/18/terriers-test-therapy-lung-disease. The WFA has provided DNA samples around the world, and the new biobank program will serve to simplify the process and speed up research. Through direct grants and support from more than 50 studies worldwide, the WFA has made an impact on the health of Westies. In fact, a major research investment in a deadly disease called craniomandibular osteopathy (CMO) has led to a critical test in the condition. https://westiefoundation.org/files/galleries/cmo-ebook.pdf

All Westies are welcome to be included in the biobank. To find out how to order a sample collection kit, visit: https://westiefoundation.org/BioBank

About Resero Genomics
Resero is a genomics services company specializing in DNA banking, genomic analysis and visualization of genetic data. At Resero, we offer clinical-grade technology for animal testing and analysis, giving customers the ability to store DNA samples in multiple safe and secure locations for up to 50 years. Based in Salt Lake City, we have extended human genome technology to DNA analysis of cattle, horses and pets. To learn more about Resero, visit: https://www.ReseroGenomics.com

About the Westie Foundation of America (WFA):
The Westie Foundation of America, Inc., (WFA) is a nonprofit corporation, recognized by the IRS as a 501(c)(3) organization. The mission of the Foundation is to provide financial assistance and other support for medical research to benefit the health and quality of life of West Highland White Terriers; and develop and communicate information regarding the health, care, breeding and quality of life of Westies to Westie owners, Westie breeders and veterinarians. To learn more about the WFA Biobank and WFA efforts, visit: https://www.WestieFoundation.org

Therese Barnes
Westie Foundation of America
+1 303-521-4080
write to us here

Comments are closed.